Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Somatoform Disorders × dexamethasone acetate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 56 Precursor Cell Lymphoblastic Leukemia-Lymphoma 16 Burkitt Lymphoma 12 Lymphoma, Mantle-Cell 6 Lymphoma, Large B-Cell, Diffuse 6 Immunoglobulin Light-chain Amyloidosis 6 Vomiting 5 Recurrence 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5 Nausea 5 Leukemia, Myeloid, Acute 5 Leukemia 5 Neoplasms, Plasma Cell 4 Neoplasm Metastasis 4 Lymphoma, Non-Hodgkin 4 Lymphoma 4 Hodgkin Disease 4 Breast Neoplasms 4 Blast Crisis 4 Smoldering Multiple Myeloma 3 Neoplasms 3 Myelodysplastic Syndromes 3 Leukemia, Myelomonocytic, Chronic 3 Brain Neoplasms 3 Sarcoma 2 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2 Plasmacytoma 2 Ovarian Neoplasms 2 Neuroblastoma 2 Lymphoma, Follicular 2

Interventions

dexamethasone acetate 1 dexamethasone 21-phosphate 1 Etoricoxib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03348696 2020-01-09

REaCT-TAPS

Ottawa Hospital Research Institute

Phase 4 Completed

Breast Neoplasms, Somatoform Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡